RESUMEN
There is still a long way ahead regarding the COVID-19 pandemic, since emerging waves remain a daunting challenge to the healthcare system. For this reason, the development of new preventive tools and therapeutic strategies to deal with the disease have been necessary, among which serological assays have played a key role in the control of COVID-19 outbreaks and vaccine development. Here, we have developed and evaluated an immunoassay capable of simultaneously detecting multiple IgG antibodies against different SARS-CoV-2 antigens through the use of Bio-PlexTM technology. Additionally, we have analyzed the antibody response in COVID-19 patients with different clinical profiles in Cadiz, Spain. The multiplex immunoassay presented is a high-throughput and robust immune response monitoring tool capable of concurrently detecting anti-S1, anti-NC and anti-RBD IgG antibodies in serum with a very high sensitivity (94.34-97.96%) and specificity (91.84-100%). Therefore, the immunoassay proposed herein may be a useful monitoring tool for individual humoral immunity against SARS-CoV-2, as well as for epidemiological surveillance. In addition, we show the values of antibodies against multiple SARS-CoV-2 antigens and their correlation with the different clinical profiles of unvaccinated COVID-19 patients in Cadiz, Spain, during the first and second waves of the pandemic.
RESUMEN
Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection triggers various events from molecular to tissue level, which in turn is given by the intrinsic characteristics of each patient. Given the molecular diversity characteristic of each cellular phenotype, the possible cytopathic, tissue and clinical effects are difficult to predict, which determines the heterogeneity of COVID-19 symptoms. The purpose of this article is to provide a comprehensive review of the cytopathic effects of SARS-CoV-2 on various cell types, focusing on the development of COVID-19, which in turn may lead, in some patients, to a persistence of symptoms after recovery from the disease, a condition known as long COVID. We describe the molecular mechanisms underlying virus-host interactions, including alterations in protein expression, intracellular signaling pathways, and immune responses. In particular, the article highlights the potential impact of these cytopathies on cellular function and clinical outcomes, such as immune dysregulation, neuropsychiatric disorders, and organ damage. The article concludes by discussing future directions for research and implications for the management and treatment of COVID-19 and long COVID.
Asunto(s)
COVID-19 , Humanos , SARS-CoV-2/metabolismo , Síndrome Post Agudo de COVID-19 , Peptidil-Dipeptidasa A/metabolismo , Interacciones Microbiota-HuespedRESUMEN
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of the Coronavirus Disease 2019 (COVID-19) pandemic, which is still a health issue worldwide mostly due to a high rate of contagiousness conferred by the high-affinity binding between cell viral receptors, Angiotensin-Converting Enzyme 2 (ACE2) and SARS-CoV-2 Spike protein. Therapies have been developed that rely on the use of antibodies or the induction of their production (vaccination), but despite vaccination being still largely protective, the efficacy of antibody-based therapies wanes with the advent of new viral variants. Chimeric Antigen Receptor (CAR) therapy has shown promise for tumors and has also been proposed for COVID-19 treatment, but as recognition of CARs still relies on antibody-derived sequences, they will still be hampered by the high evasion capacity of the virus. In this manuscript, we show the results from CAR-like constructs with a recognition domain based on the ACE2 viral receptor, whose ability to bind the virus will not wane, as Spike/ACE2 interaction is pivotal for viral entry. Moreover, we have developed a CAR construct based on an affinity-optimized ACE2 and showed that both wild-type and affinity-optimized ACE2 CARs drive activation of a T cell line in response to SARS-CoV-2 Spike protein expressed on a pulmonary cell line. Our work sets the stage for the development of CAR-like constructs against infectious agents that would not be affected by viral escape mutations and could be developed as soon as the receptor is identified.
Asunto(s)
COVID-19 , Humanos , SARS-CoV-2/metabolismo , Glicoproteína de la Espiga del Coronavirus/química , Enzima Convertidora de Angiotensina 2/metabolismo , Unión Proteica , Tratamiento Farmacológico de COVID-19 , Linfocitos T/metabolismo , Proteínas Portadoras/metabolismoRESUMEN
Colorectal cancer (CRC) is one of the main causes of cancer death in the world. Post-translational modifications (PTMs) have been extensively studied in malignancies due to its relevance in tumor pathogenesis and therapy. This review is focused on the dysregulation of glycosyltransferase expression in CRC and its impact in cell function and in several biological pathways associated with CRC pathogenesis, prognosis and therapeutic approaches. Glycan structures act as interface molecules between cells and their environment and in several cases facilitate molecule function. CRC tissue shows alterations in glycan structures decorating molecules, such as annexin-1, mucins, heat shock protein 90 (Hsp90), ß1 integrin, carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), insulin-like growth factor-binding protein 3 (IGFBP3), transforming growth factor beta (TGF-ß) receptors, Fas (CD95), PD-L1, decorin, sorbin and SH3 domain-containing protein 1 (SORBS1), CD147 and glycosphingolipids. All of these are described as key molecules in oncogenesis and metastasis. Therefore, glycosylation in CRC can affect cell migration, cell-cell adhesion, actin polymerization, mitosis, cell membrane repair, apoptosis, cell differentiation, stemness regulation, intestinal mucosal barrier integrity, immune system regulation, T cell polarization and gut microbiota composition; all such functions are associated with the prognosis and evolution of the disease. According to these findings, multiple strategies have been evaluated to alter oligosaccharide processing and to modify glycoconjugate structures in order to control CRC progression and prevent metastasis. Additionally, immunotherapy approaches have contemplated the use of neo-antigens, generated by altered glycosylation, as targets for tumor-specific T cells or engineered CAR (Chimeric antigen receptors) T cells.
Asunto(s)
Neoplasias Colorrectales/genética , Glicoesfingolípidos/inmunología , Glicosiltransferasas/genética , Mucinas/genética , Proteínas de Neoplasias/genética , Procesamiento Proteico-Postraduccional , Anexina A1/genética , Anexina A1/inmunología , Neoplasias Colorrectales/inmunología , Neoplasias Colorrectales/patología , Neoplasias Colorrectales/terapia , Decorina/genética , Decorina/inmunología , Receptores ErbB/genética , Receptores ErbB/inmunología , Regulación Neoplásica de la Expresión Génica , Glicoesfingolípidos/metabolismo , Glicosilación , Glicosiltransferasas/inmunología , Humanos , Inmunoterapia Adoptiva/métodos , Proteína 3 de Unión a Factor de Crecimiento Similar a la Insulina/genética , Proteína 3 de Unión a Factor de Crecimiento Similar a la Insulina/inmunología , Integrina beta1/genética , Integrina beta1/inmunología , Proteínas de Microfilamentos/genética , Proteínas de Microfilamentos/inmunología , Mucinas/inmunología , Proteínas de Neoplasias/inmunología , Receptor fas/genética , Receptor fas/inmunologíaRESUMEN
BACKGROUND: In this review, we were interested to identify the wide universe of enzymes associated with epigenetic modifications, whose gene expression is regulated by miRNAs with a high relative abundance in Crohn's disease (CD) affected tissues, with the aim to determine their impact in the pathogenesis and evolution of the disease. METHODS: We used HMDD and Bibliometrix R-package in order to identify the miRNAs overexpressed in CD. The identified enzymes associated with epigenetic mechanisms and post-translational modifications, regulated by miRNAs upregulated in CD, were analyzed using String v11 database. RESULTS: We found 190 miRNAs with great abundance in patients with CD, of which 26 miRNAs regulate the gene expression of enzymes known to catalyze epigenetic modifications involved in essentials pathophysiological processes, such as chromatin architecture reorganization, immune response regulation including CD4+ T cells polarization, integrity of gut mucosa, gut microbiota composition and tumorigenesis. CONCLUSION: The integrated analysis of miRNAs with a high relative abundance in patients with CD showed a combined and superimposed gene expression regulation of enzymes associated with relevant epigenetic mechanisms and that could explain, in part, the pathogenesis of CD.
Asunto(s)
Enfermedad de Crohn/enzimología , Enfermedad de Crohn/genética , MicroARNs/genética , Linfocitos T CD4-Positivos/metabolismo , Ensamble y Desensamble de Cromatina/genética , Islas de CpG , Enfermedad de Crohn/fisiopatología , Metilación de ADN , Epigénesis Genética , Regulación de la Expresión Génica , Humanos , Inmunidad/genética , Mapas de Interacción de Proteínas/genética , Procesamiento Proteico-Postraduccional/genéticaRESUMEN
Introducción: Un estilo de vida poco activo y una dieta inadecuada podrían influir en el desarrollo de futuras enfermedades cardiometabólicas. El objetivo principal fue determinar la asociación entre capacidad aeróbica y factores de riesgo cardiometabólicos y si dicha posible asociación es independiente de la dieta mediterránea (DM). A su vez, se plantea como objetivo secundario estudiar el efecto combinado de la capacidad aeróbica y la adherencia a la DM sobre el índice de riesgo cardiometabólico global (IRCM) en adultos. Métodos: Se evaluó a 79 adultos (38% mujeres) entre 18 y 40 años en Cádiz. Se midieron indicadores de adiposidad, presión arterial, triglicéridos, glucosa y perfil inflamatorio (interleucina-6 y factor de necrosis tumoral) y se desarrolló un IRCM. Se midió la capacidad aeróbica mediante el consumo máximo de oxígeno a través de una prueba de esfuerzo incremental en cicloergómetro. La adherencia a la DM se evaluó mediante cuestionario. Se utilizó un modelo de regresión lineal para estudiar la asociación entre capacidad aeróbica y factores de riesgo cardiometabólicos con diferentes modelos de ajuste. Se analizó el efecto combinado de la capacidad aeróbica y la adherencia a la DM sobre el IRCM mediante el test de ANOVA, con nivel de significación de p < 0,05 en Bonferroni. Resultados: Se observó asociación negativa entre la capacidad aeróbica y los factores de riesgo cardiometabólicos (todas p ≤ 0,05) en el modelo sin ajustar. La presión arterial y los triglicéridos perdieron la asociación tras ajustar el modelo por sexo, edad y adherencia a la DM. Los participantes con alta capacidad aeróbica y alta adherencia a la DM mostraron un menor IRCM (-1,083 ± 2,325 vs. 2,802 ± 1,759). Conclusiones: La capacidad aeróbica se asocia de forma inversa con factores de riesgo cardiometabólicos relacionados con la adiposidad, independientemente de la adherencia a la DM. Una alta adherencia a la DM podría influir en la modulación de la presión arterial. Una alta capacidad aeróbica podría reducir las consecuencias adversas de una baja adherencia a la DM
Introduction: Unhealthy lifestyle and inadequate diet could influence the development of future cardiometabolic disease. The main aim of this study was to determine the association between aerobic fitness and cardiometabolic risk factors in adults, whether this relation is depends of adherence to Mediterranean diet (MD). A secondary aim was to study the combined effect of aerobic capacity and adherence to MD on global cardiometabolic risk score (CMRS). Method: A total of 79 adults (38% women) enrolled between 18-40 year from Cádiz. We measured adiposity indicators, blood pressure, triglycerides, glucose and inflammatory profile (interleukin-6 and tumor necrosis factor) and was computed (CMRS). Aerobic fitness was measured by maximal oxygen comsuption through an incremental stress test by cycleergometer. The MD patterns was measured using the questionnaire of adherence to MD. The association between aerobic fitness and cardiometabolic risk factors was examined using a lineal regression and it was adjusted for different confounders. CMRS on the lifestyle was analyzed using the ANOVA test, with statistical significance level of P < 0.05 in Bonferroni. Results: Linear regression showed inverse association between aerobic fitness and cardiometabolic risk factors (all P ≤ 0.05) in the model without adjustment. Blood pressure and triglycerides lost the association after adjust model for sex, age, and adherence to MD. Participants with high aerobic fitness and high adherence to MD show a lowest CMRS (-1.083 ± 2.325 vs. 2.802 ± 1.759). Conclusions: Aerobic fitness was inversely associated with fatness risk factors, that relationship is independent to adherence to MD. A high adherence to MD could modulate blood pressure. A combination of high aerobic capacity and high adherence to MD could reduce the adverse consecuence of a low adherencie to MD
Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto Joven , Adulto , Dieta Mediterránea , Factores de Riesgo , Capacidad Cardiovascular , Adiposidad , Presión Arterial , Consumo de Oxígeno , Encuestas y Cuestionarios , Modelos Lineales , Análisis de Varianza , Triglicéridos , AntropometríaRESUMEN
BACKGROUND: Diabetes is a risk factor for developing Alzheimer's disease (AD); however, the mechanism by which diabetes can promote AD pathology remains unknown. Diabetes results in diverse molecular changes in the brain, including dysregulation of glucose metabolism and loss of cerebrovascular homeostasis. Although these changes have been associated with increased Aß pathology and increased expression of glial activation markers in APPswe/PS1dE9 (APP/PS1) mice, there has been limited characterization, to date, of the neuroinflammatory changes associated with diabetic conditions. METHODS: To more fully elucidate neuroinflammatory changes associated with diabetes that may drive AD pathology, we combined the APP/PS1 mouse model with either high-fat diet (HFD, a model of pre-diabetes), the genetic db/db model of type 2 diabetes, or the streptozotocin (STZ) model of type 1 diabetes. We then used a multiplexed immunoassay to quantify cortical changes in cytokine proteins. RESULTS: Our analysis revealed that pathology associated with either db/db, HFD, or STZ models yielded upregulation of a broad profile of cytokines, including chemokines (e.g., MIP-1α, MIP-1ß, and MCP-1) and pro-inflammatory cytokines, including IL-1α, IFN-γ, and IL-3. Moreover, multivariate partial least squares regression analysis showed that combined diabetic-APP/PS1 models yielded cooperatively enhanced expression of the cytokine profile associated with each diabetic model alone. Finally, in APP/PS1xdb/db mice, we found that circulating levels of Aß1-40, Aß1-42, glucose, and insulin all correlated with cytokine expression in the brain, suggesting a strong relationship between peripheral changes and brain pathology. CONCLUSIONS: Altogether, our multiplexed analysis of cytokines shows that Alzheimer's and diabetic pathologies cooperate to enhance profiles of cytokines reported to be involved in both diseases. Moreover, since many of the identified cytokines promote neuronal injury, Aß and tau pathology, and breakdown of the blood-brain barrier, our data suggest that neuroinflammation may mediate the effects of diabetes on AD pathogenesis. Therefore, strategies targeting neuroinflammatory signaling, as well as metabolic control, may provide a promising strategy for intervening in the development of diabetes-associated AD.
Asunto(s)
Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/farmacología , Citocinas/biosíntesis , Diabetes Mellitus Experimental/metabolismo , Péptidos beta-Amiloides/sangre , Animales , Glucemia/análisis , Corteza Cerebral/metabolismo , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/metabolismo , Dieta Alta en Grasa , Humanos , Insulina/sangre , Ratones , Ratones Transgénicos , Microglía/metabolismo , EstreptozocinaRESUMEN
INTRODUCTION: Unhealthy lifestyle and inadequate diet could influence the development of future cardiometabolic disease. The main aim of this study was to determine the association between aerobic fitness and cardiometabolic risk factors in adults, whether this relation is depends of adherence to Mediterranean diet (MD). A secondary aim was to study the combined effect of aerobic capacity and adherence to MD on global cardiometabolic risk score (CMRS). METHOD: A total of 79 adults (38% women) enrolled between 18-40 year from Cádiz. We measured adiposity indicators, blood pressure, triglycerides, glucose and inflammatory profile (interleukin-6 and tumor necrosis factor) and was computed (CMRS). Aerobic fitness was measured by maximal oxygen comsuption through an incremental stress test by cycleergometer. The MD patterns was measured using the questionnaire of adherence to MD. The association between aerobic fitness and cardiometabolic risk factors was examined using a lineal regression and it was adjusted for different confounders. CMRS on the lifestyle was analyzed using the ANOVA test, with statistical significance level of P<0.05 in Bonferroni. RESULTS: Linear regression showed inverse association between aerobic fitness and cardiometabolic risk factors (all P≤0.05) in the model without adjustment. Blood pressure and triglycerides lost the association after adjust model for sex, age, and adherence to MD. Participants with high aerobic fitness and high adherence to MD show a lowest CMRS (-1.083±2.325 vs. 2.802±1.759). CONCLUSIONS: Aerobic fitness was inversely associated with fatness risk factors, that relationship is independent to adherence to MD. A high adherence to MD could modulate blood pressure. A combination of high aerobic capacity and high adherence to MD could reduce the adverse consecuence of a low adherencie to MD.
Asunto(s)
Factores de Riesgo Cardiometabólico , Dieta Mediterránea , Ejercicio Físico , Adolescente , Adulto , Estudios Transversales , Femenino , Humanos , Masculino , Adulto JovenRESUMEN
Glioblastoma (GB), the most aggressive malignant glioma, is made up of a large percentage of glioma-associated microglia/macrophages (GAM), suggesting that immune cells play an important role in the pathophysiology of GB. Under physiological conditions, microglia, the phagocytes of the central nervous system (CNS), are involved in various processes such as neurogenesis or axonal growth, and the progression of different conditions such as Alzheimer's disease. Through immunohistochemical studies, markers that enhance GB invasiveness have been shown to be expressed in the peritumoral area of ââthe brain, such as Transforming Growth Factor α (TGF-α), Stromal Sell-Derived Factor 1 (SDF1/CXCL12), Sphingosine-1-Phosphate (S1P) and Neurotrophic Factor Derived from the Glial cell line (GDNF), contributing to the increase in tumor mass. Similarly, it has also been described 17 biomarkers that are present in hypoxic periarteriolar HSC niches in bone marrow and in hypoxic periarteriolar GSC niches in glioblastoma. Interestingly, microglia plays an important role in the microenvironment that supports GB progression, being one of the most important focal points in the study of therapeutic targets for the development of new drugs. In this review, we describe the altered signaling pathways in microglia in the context of GB. We also show how microglia interact with glioblastoma cells and the epigenetic mechanisms involved. Regarding the interactions between microglia and neurogenic niches, some authors indicate that glioblastoma stem cells (GSC) are similar to neural stem cells (NSC), common stem cells in the subventricular zone (SVZ), suggesting that this could be the origin of GB. Understanding the similarities between SVZ and the tumor microenvironment could be important to clarify some mechanisms involved in GB malignancy and to support the discovering of new therapeutic targets for the development of more effective glioblastoma treatments.
RESUMEN
The aim of this study was to identity in silico the relationships among microRNAs (miRNAs) and genes encoding transcription factors, ubiquitylation, DNA methylation, and histone modifications in systemic lupus erythematosus (SLE). To identify miRNA dysregulation in SLE, we used miR2Disease and PhenomiR for information about miRNAs exhibiting differential regulation in disease and other biological processes, and HMDD for information about experimentally supported human miRNA-disease association data from genetics, epigenetics, circulating miRNAs, and miRNA-target interactions. This information was incorporated into the miRNA analysis. High-throughput sequencing revealed circulating miRNAs associated with kidney damage in patients with SLE. As the main finding of our in silico analysis of miRNAs differentially expressed in SLE and their interactions with disease-susceptibility genes, post-translational modifications, and transcription factors; we highlight 226 miRNAs associated with genes and processes. Moreover, we highlight that alterations of miRNAs such as hsa-miR-30a-5p, hsa-miR-16-5p, hsa-miR-142-5p, and hsa-miR-324-3p are most commonly associated with post-translational modifications. In addition, altered miRNAs that are most frequently associated with susceptibility-related genes are hsa-miR-16-5p, hsa-miR-374a-5p, hsa-miR-34a-5p, hsa-miR-31-5p, and hsa-miR-1-3p.
Asunto(s)
Epigénesis Genética , Lupus Eritematoso Sistémico/genética , MicroARNs/genética , Bases de Datos Genéticas , Ontología de Genes , Redes Reguladoras de Genes , Estudios de Asociación Genética , Humanos , MicroARNs/metabolismo , Procesamiento Proteico-PostraduccionalRESUMEN
Hydrophilic and homogeneous sub-10 nm blue light-emitting gold nanoparticles (NPs) functionalized with different capping agents have been prepared by simple chemical routes. Structure, average, size, and surface characteristics of these NPs have been widely studied, and the stability of colloidal NP solutions at different pH values has been evaluated. Au NPs show blue PL emission, particularly in the GSH capped NPs, in which the thiol-metal core transference transitions considerably enhance the fluorescent emission. The influence of capping agent and NP size on cytotoxicity and on the fluorescent emission are analyzed and discussed in order to obtain Au NPs with suitable features for biomedical applications. Cytotoxicity of different types of gold NPs has been determined using NPs at high concentrations in both tumor cell lines and primary cells. All NPs used show high biocompatibility with low cytotoxicity even at high concentration, while Au-GSH NPs decrease viability and proliferation of both a tumor cell line and primary lymphocytes.
RESUMEN
The defining characteristic of neural stem cells (NSCs) is their ability to multiply through symmetric divisions and proliferation, and differentiation by asymmetric divisions, thus giving rise to different types of cells of the central nervous system (CNS). A strict temporal space control of the NSC differentiation is necessary, because its alterations are associated with neurological dysfunctions and, in some cases, death. This work reviews the current state of the molecular mechanisms that regulate the transcription in NSCs, organized according to whether the origin of the stimulus that triggers the molecular cascade in the CNS is internal (intrinsic factors) or whether it is the result of the microenvironment that surrounds the CNS (extrinsic factors).
RESUMEN
The adaptor protein linker for activation of T cells (LAT) has an essential role transducing activatory intracellular signals coming from the TCR/CD3 complex. Previous reports have shown that upon T-cell activation, LAT interacts with the tyrosine kinase Lck, leading to the inhibition of its kinase activity. LAT-Lck interaction seemed to depend on a stretch of negatively charged amino acids in LAT. Here, we have substituted this segment of LAT between amino acids 113 and 126 with a non-charged segment and expressed the mutant LAT (LAT-NIL) in J.CaM2 cells in order to analyze TCR signaling. Substitution of this segment in LAT prevented the activation-induced interaction with Lck. Moreover, cells expressing this mutant form of LAT showed a statistically significant increase of proximal intracellular signals such as phosphorylation of LAT in tyrosine residues 171 and 191, and also enhanced ZAP70 phosphorylation approaching borderline statistical significance (p = 0.051). Nevertheless, downstream signals such as Ca2+ influx or MAPK pathways were partially inhibited. Overall, our data reveal that LAT-Lck interaction constitutes a key element regulating proximal intracellular signals coming from the TCR/CD3 complex.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/metabolismo , Aminoácidos/metabolismo , Proteína Tirosina Quinasa p56(lck) Específica de Linfocito/metabolismo , Proteínas de la Membrana/metabolismo , Receptores de Antígenos de Linfocitos T/metabolismo , Línea Celular , Humanos , Proteína Tirosina Quinasa ZAP-70/metabolismoRESUMEN
Endothelial progenitor cells (EPCs) constitute a promising alternative in cardiovascular regenerative medicine due to their assigned role in angiogenesis and vascular repair. In response to injury, EPCs promote vascular remodeling by replacement of damaged endothelial cells and/or by secreting angiogenic factors over the damaged tissue. Nevertheless, such mechanisms need to be further characterized. In the current approach we have evaluated the initial response of early EPCs (eEPCs) from healthy individuals after direct contact with the factors released by carotid arteries complicated with atherosclerotic plaques (AP), in order to understand the mechanisms underlying the neovascularization and remodeling properties assigned to these cells. Herein, we found that the AP secretome stimulated eEPCs proliferation and mobilization ex vivo, and such increase was accompanied by augmented permeability, cell contraction and also an increase of cell-cell adhesion in association with raised vinculin levels. Furthermore, a comparative mass spectrometry analysis of control versus stimulated eEPCs revealed a differential expression of proteins in the AP treated cells, mostly involved in cell migration, proliferation and vascular remodeling. Some of these protein changes were also detected in the eEPCs isolated from atherosclerotic patients compared to eEPCs from healthy donors. We have shown, for the first time, that the AP released factors activate eEPCs ex vivo by inducing their mobilization together with the expression of vasculogenic related markers. The present approach could be taken as a ex vivo model to study the initial activation of vascular cells in atherosclerosis and also to evaluate strategies looking to potentiate the mobilization of EPCs prior to clinical applications.
Asunto(s)
Células Progenitoras Endoteliales/metabolismo , Placa Aterosclerótica/metabolismo , Proteoma , Movimiento Celular , Proliferación Celular , Supervivencia Celular , Células Cultivadas , Humanos , Permeabilidad , Placa Aterosclerótica/patología , Proteómica/métodosRESUMEN
Hepatitis C virus core protein is a highly basic viral protein that multimerizes with itself to form the viral capsid. When expressed in CD4+ T lymphocytes, it can induce modifications in several essential cellular and biological networks. To shed light on the mechanisms underlying the alterations caused by the viral protein, we have analyzed HCV-core subcellular localization and its associations with host proteins in Jurkat T cells. In order to investigate the intracellular localization of Hepatitis C virus core protein, we have used a lentiviral system to transduce Jurkat T cells and subsequently localize the protein using immunoelectron microscopy techniques. We found that in Jurkat T cells, Hepatitis C virus core protein mostly localizes in the nucleus and specifically in the nucleolus. In addition, we performed pull-down assays combined with Mass Spectrometry Analysis, to identify proteins that associate with Hepatitis C virus core in Jurkat T cells. We found proteins such as NOLC1, PP1γ, ILF3, and C1QBP implicated in localization and/or traffic to the nucleolus. HCV-core associated proteins are implicated in RNA processing and RNA virus infection as well as in functions previously shown to be altered in Hepatitis C virus core expressing CD4+ T cells, such as cell cycle delay, decreased proliferation, and induction of a regulatory phenotype. Thus, in the current work, we show the ultrastructural localization of Hepatitis C virus core and the first profile of HCV core associated proteins in T cells, and we discuss the functions and interconnections of these proteins in molecular networks where relevant biological modifications have been described upon the expression of Hepatitis C virus core protein. Thereby, the current work constitutes a necessary step toward understanding the mechanisms underlying HCV core mediated alterations that had been described in relevant biological processes in CD4+ T cells.
RESUMEN
Non-T cell activation linker is an adaptor protein that is tyrosine phosphorylated upon cross-linking of immune receptors expressed on B lymphocytes, NK cells, macrophages, basophils, or mast cells, allowing the recruitment of cytosolic mediators for downstream signaling pathways. Fas receptor acts mainly as a death receptor, and when cross-linked with Fas ligand, many proteins are proteolytically cleaved, including several signaling molecules in T and B cells. Fas receptor triggering also interferes with TCR intracellular signals, probably by means of proteolytic cleavage of several adaptor proteins. We have previously found that the adaptor linker for activation of T cells, evolutionarily related to non-T cell activation linker, is cleaved upon proapoptotic stimuli in T lymphocytes and thymocytes, in a tyrosine phosphorylation-dependent fashion. Here, we describe non-T cell activation linker proteolytic cleavage triggered in human B cells and monocytes by Fas cross-linking and staurosporine treatment. Non-T cell activation linker is cleaved, producing an N-terminal fragment of â¼22 kDa, and such cleavage is abrogated in the presence of caspase 8/granzyme B and caspase 3 inhibitors. Moreover, we have identified an aspartic acid residue at which non-T cell activation linker is cleaved, which similar to linker for activation of T cells, this aspartic acid residue is located close to tyrosine and serine residues, suggesting an interdependence of phosphorylation and proteolytic cleavage. Consistently, induction of non-T cell activation linker phosphorylation by pervanadate inhibits its cleavage. Interestingly, the truncated isoform of non-T cell activation linker, generated after cleavage, has a decreased signaling ability when compared with the full-length molecule. Altogether, our results suggest that cleavage of transmembrane adaptors constitutes a general mechanism for signal termination of immune receptors.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/metabolismo , Linfocitos B/metabolismo , Caspasa 3/metabolismo , Caspasa 8/metabolismo , Proteína Ligando Fas/metabolismo , Receptor fas/metabolismo , Linfocitos B/citología , Células Cultivadas , Humanos , Células Jurkat , Activación de Linfocitos , Fosforilación , Proteolisis , Transducción de Señal , TirosinaRESUMEN
Adaptive T cell responses are critical for controlling HCV infection. While there is clinical evidence of a relevant role for regulatory T cells in chronic HCV-infected patients, based on their increased number and function; mechanisms underlying such a phenomena are still poorly understood. Accumulating evidence suggests that proteins from Hepatitis C virus can suppress host immune responses. We and others have shown that HCV is present in CD4+ lymphocytes from chronically infected patients and that HCV-core protein induces a state of unresponsiveness in the CD4+ tumor cell line Jurkat. Here we show that CD4+ primary T cells lentivirally transduced with HCV-core, not only acquire an anergic phenotype but also inhibit IL-2 production and proliferation of bystander CD4+ or CD8+ T cells in response to anti-CD3 plus anti-CD28 stimulation. Core-transduced CD4+ T cells show a phenotype characterized by an increased basal secretion of the regulatory cytokine IL-10, a decreased IFN-γ production upon stimulation, as well as expression of regulatory T cell markers, CTLA-4, and Foxp3. A significant induction of CD4+CD25+CD127(low)PD-1(high)TIM-3(high) regulatory T cells with an exhausted phenotype was also observed. Moreover, CCR7 expression decreased in HCV-core expressing CD4+ T cells explaining their sequestration in inflamed tissues such as the infected liver. This work provides a new perspective on de novo generation of regulatory CD4+ T cells in the periphery, induced by the expression of a single viral protein.
Asunto(s)
Linfocitos T CD4-Positivos/metabolismo , Linfocitos T CD8-positivos/metabolismo , Factores de Transcripción Forkhead/metabolismo , Hepacivirus/metabolismo , Interleucina-10/metabolismo , Proteínas del Núcleo Viral/metabolismo , Línea Celular , Proliferación Celular , Células Cultivadas , HumanosRESUMEN
HCV (hepatitis C virus) infection is a serious health care problem that affects more than 170 million people worldwide. Viral clearance depends on the development of a successful cellular immune response against the virus. Interestingly, such a response is altered in chronically infected patients, leading to chronic hepatitis that can result in liver fibrosis, cirrhosis and hepatocellular carcinoma. Among the mechanisms that have been described as being responsible for the immune suppression caused by the virus, Treg-cells (regulatory T-cells) are emerging as an essential component. In the present work we aim to study the effect of HCV-core protein in the development of T-cells with regulatory-like function. Using a third-generation lentiviral system to express HCV-core in CD4+ Jurkat T-cells, we describe that HCV-core-expressing Jurkat cells show an up-regulation of FOXP3 (forkhead box P3) and CTLA-4 (cytotoxic T-lymphocyte antigen-4). Moreover, we show that HCV-core-transduced Jurkat cells are able to suppress CD4+ and CD8+ T-cell responses to anti-CD3 plus anti-CD28 stimulation.
Asunto(s)
Factores de Transcripción Forkhead/metabolismo , Hepacivirus/inmunología , Antígenos de la Hepatitis C/metabolismo , Hepatitis C Crónica/inmunología , Inmunidad Celular , Linfocitos T Reguladores/metabolismo , Proteínas del Núcleo Viral/metabolismo , Western Blotting , Linfocitos T CD8-positivos/metabolismo , Linfocitos T CD8-positivos/virología , Antígeno CTLA-4/metabolismo , Electroforesis en Gel de Poliacrilamida , Humanos , Interleucina-2/metabolismo , Subunidad alfa del Receptor de Interleucina-2/metabolismo , Células Jurkat , Reacción en Cadena en Tiempo Real de la Polimerasa , Linfocitos T Reguladores/virología , Transducción Genética , Regulación hacia ArribaRESUMEN
CTLA-4 (Antígeno-4 asociado al Linfocito T Citotóxico) es una molécula expresada en la superficiede la mayoría de los linfocitos T activados. Su función es regular la homeostasis y la tolerancia periféricainmunológica inhibiendo la activación de los linfocitos T. Dos mecanismos han sido postuladospara mediar la inhibición por CTLA-4 de la respuesta de los linfocitos T: Señalización negativa yantagonismo competitivo de la vía de coestimulación mediada por CD28/B7. Las diferentes moléculasque participan en la activación e inactivación de los linfocitos T han sido analizadas con el objetivode diseñar estrategias terapéuticas de tolerancia inmunológica. Los progresos han estado basados enlos mecanismos de activación linfocitaria, la coestimulación o la señalización por citocinas, pero hasido difícil diseñar terapias de inhibición endógena. La molécula CTLA-4 ha sido el blanco de muchosestudios, los cuales han planteado diferentes estrategias novedosas para inducir inmunosupresión,algunos antígeno específicos, que se han convertido en nuevos pilares en el tratamiento de las enfermedadesautoinmunes y rechazo de transplantes.
CTLA-4 (Cytotoxic T lymphocyte-associated Ag-4) is a molecule expressed on the surface of activatedT lymphocytes, the function of CTLA-4 is regulate T cell homeostasis and peripheral immunetolerance, inhibiting T cell activation. Two mechanisms have been postulated to mediate CTLA-4inhibition of T cell responses: Negative signaling and competitive antagonism of CD28:B7-mediatedcostimulation. The different participating molecules in T cell activation and T cell inactivationhave been analyzed to design therapeutic strategies for immune tolerance. The progress has beenbased upon interference with lymphocyte activation, costimulation, or cytokine signals, but It hasbeen very difficult to design therapeutic strategies that specifically enhance endogenous inhibitorypathways. CTLA-4 has been the target of several studies, that have brought forward d...
Asunto(s)
Humanos , Células , Terapia de Inmunosupresión , Linfocitos , Tolerancia Inmunológica , Enfermedades Autoinmunes , Inmunidad , Receptores de CitocinasRESUMEN
El Síndrome de Moebius (MBS) es una enfermedad rara, caracterizada principalmente por parálisisfacial y frecuentemente acompañada de alteraciones oculares asociadas al compromiso del VI nerviocraneal. Además es frecuente encontrar anomalías orofaciales y de miembros en estos pacientes.En este artículo se presenta un paciente masculino de nueve meses con el cuadro clínico de Síndromede Moebius en el cual se discuten los aspectos genéticos y medioambientales asociados a esta patología.Desde la introducción del misoprostol y su uso inadecuado como agente abortivo, se ha observadoun incremento en la frecuencia de recién nacidos con Síndrome de Moebius asociados al uso de estemedicamento. Al día de hoy, tanto el factor genético como el factor medioambiental se encuentranasociados al Síndrome de Moebius. Finalmente, es importante alertar a la comunidad médica y a lapoblación en general acerca del riesgo teratogénico del misoprostol y de la importancia del consejogenético cuando nace un paciente con Síndrome de Moebius.
Moebius syndrome is a rare disorder mainly characterized by a facial paralyisis and ocular anomaliesinvolving the sixth craneal nerve. In addition malformations of orofacial structures and limbs arefrequently founded.In this case, a nine months old boy with Moebius syndrome is presented, clinical findings are describedand genetic or environmental aspects are discussed. Since the use of Misoprostol for abortion withoutmedical indication the number of newborn with Moebius syndrome has increased in the population.Nowadays, either genetic or environmental factors are associated with Moebius syndrome. However, itis necessary to alert general and medical community about the risk of teratogenic effects of Misoprostoldrug and about the genetic counselling utility when there is a newborn with Moebius syndrome.